Hillevax

Hillevax EBIT/Assets

Delisted

The Operating Income to Assets Ratio (EBIT/Assets) of Hillevax (HLVX) as of Nov 20, 2026 is -80.59 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -38.71 % — a change of 108.17% (lower).

EBIT/Assets

-80.59 %

YoY

108.17%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Hillevax is 2024 -80.59 % . Operating Income to Assets Ratio (EBIT/Assets) of Hillevax was 2023 -38.71 % . It decreases by 108.17% lower compared to the previous year.

The Hillevax EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2019
-140.35 USD
Jan 1, 2020
-256.44 USD
Jan 1, 2021
-42.02 USD
Jan 1, 2022
-20.53 USD
Jan 1, 2023
-38.71 USD
Jan 1, 2024
-80.59 USD
The Hillevax EBIT/Assets history
YEAREBIT/AssetsYoY
-80.59 %+108.17%
-38.71 %+88.60%
-20.53 %-51.14%
-42.02 %-83.62%
-256.44 %+82.71%
-140.35 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hillevax Stock analysis

What does Hillevax do? HilleVax, Inc. develops and commercializes novel vaccines, focusing on HIL-214, a bivalent virus-like particle (VLP) vaccine candidate for norovirus-induced acute gastroenteritis. The vaccine combines VLPs for norovirus genotypes GI.1 and GII.4 with an aluminum hydroxide adjuvant to enhance immune response. HIL-214 targets moderate-to-severe cases of norovirus infection, which causes symptoms like diarrhea, vomiting, and dehydration. The company's primary revenue stream will come from the future commercialization of HIL-214 after regulatory approval, with potential sales to healthcare providers and public health programs. Hillevax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hillevax stock

Operating Income to Assets Ratio (EBIT/Assets) of Hillevax is -80.59 % in 2024.

Operating Income to Assets Ratio (EBIT/Assets) of Hillevax changed from -38.71 % to -80.59 %, representing a 108.17% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Hillevax since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Hillevax with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Hillevax

All Key Metrics — Hillevax